BBNX logo

Beta Bionics, Inc. (BBNX) Cash From Operations

Annual CFO:

-$48.27M-$15.83M(-48.78%)
December 31, 2024

Summary

  • As of today, BBNX annual cash from operations is -$48.27 million, with the most recent change of -$15.83 million (-48.78%) on December 31, 2024.
  • During the last 3 years, BBNX annual cash from operations has risen by +$11.94 million (+19.82%).
  • BBNX annual cash from operations is now -48.78% below its all-time high of -$32.45 million, reached on December 31, 2023.

Performance

1-Year Change

-48.78%

3-Year Change

+19.82%

5-Year Change

+19.82%

15-Year Change

+19.82%

BBNX Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

26.05%
BBNX annual cash from operations is higher than 26.05% of companies in Healthcare sector

Range

All-Time High

-$32.45M
BBNX annual cash from operations is currently -48.78% below its historical high of -$32.45 million

3-Year Low

-$60.21M
BBNX annual cash from operations is currently +19.82% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
BBNX previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

Mar 24, 2026
BBNX next annual earnings announcement is scheduled for Mar 24, 2026

OtherBBNXcash flow metrics

Annual CFI

-$3.48M
BBNX annual cash from investing is -$3.48 million

Annual CFF

$55.62M
BBNX annual cash from financing is $55.62 million

Annual FCF

-$51.67M
BBNX annual free cash flow is -$51.67 million

Annual CAPEX

$3.40M
BBNX annual capital expenditures is $3.40 million

Quarterly CFO:

-$8.73M+$4.87M(+35.79%)
September 30, 2025

Summary

  • As of today, BBNX quarterly cash from operations is -$8.73 million, with the most recent change of +$4.87 million (+35.79%) on September 30, 2025.
  • Over the past year, BBNX quarterly cash from operations has increased by +$884.00 thousand (+9.20%).
  • BBNX quarterly cash from operations is now -37.53% below its all-time high of -$6.35 million, reached on December 31, 2023.

Performance

3-Month Change

+35.79%

1-Year Change

+9.2%

3-Year Change

+66.55%

5-Year Change

+66.55%

BBNX Quarterly Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

31.19%
BBNX quarterly cash from operations is higher than 31.19% of companies in Healthcare sector

Range

All-Time High

-$6.35M
BBNX quarterly cash from operations is currently -37.53% below its historical high of -$6.35 million

3-Year Low

-$26.10M
BBNX quarterly cash from operations is currently +66.55% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2025
BBNX previous earnings announcement was published on Sep 30, 2025

Next Quarterly Earnings Report Date

Mar 24, 2026
BBNX next earnings announcement is scheduled for Mar 24, 2026

OtherBBNXcash flow metrics

Quarterly CFI

$9.49M
BBNX quarterly cash from investing is $9.49 million

Quarterly CFF

$2.65M
BBNX quarterly cash from financing is $2.65 million

Quarterly FCF

-$10.01M
BBNX quarterly free cash flow is -$10.01 million

Quarterly CAPEX

$1.28M
BBNX quarterly capital expenditures is $1.28 million

TTM CFO:

-$56.58M+$884.00K(+1.54%)
September 30, 2025

Summary

  • As of today, BBNX TTM cash from operations is -$56.58 million, with the most recent change of +$884.00 thousand (+1.54%) on September 30, 2025.
  • Over the past year, BBNX TTM cash from operations has dropped by -$16.24 million (-40.25%).
  • BBNX TTM cash from operations is now -116.79% below its all-time high of -$26.10 million, reached on September 30, 2023.

Performance

3-Month Change

+1.54%

1-Year Change

-40.25%

3-Year Change

-116.79%

5-Year Change

-116.79%

BBNX TTM Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

23.93%
BBNX TTM cash from operations is higher than 23.93% of companies in Healthcare sector

Range

All-Time High

-$26.10M
BBNX TTM cash from operations is currently -116.79% below its historical high of -$26.10 million

3-Year Low

-$57.46M
BBNX TTM cash from operations is currently +1.54% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2025
BBNX previous earnings announcement was published on Sep 30, 2025

Next Quarterly Earnings Report Date

Mar 24, 2026
BBNX next earnings announcement is scheduled for Mar 24, 2026

OtherBBNXcash flow metrics

TTM CFI

-$193.13M
BBNX TTM cash from investing is -$193.13 million

TTM CFF

$270.71M
BBNX TTM cash from financing is $270.71 million

TTM FCF

-$60.53M
BBNX TTM free cash flow is -$60.53 million

TTM CAPEX

$3.96M
BBNX TTM capital expenditures is $3.96 million

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

BBNX Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-48.8%+9.2%-40.3%
3Y3 Years+19.8%+66.5%-116.8%
5Y5 Years+19.8%+66.5%-116.8%

BBNX Cash From Operations Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-48.8%+19.8%-37.5%+66.5%-116.8%+1.5%
5Y5-Year-48.8%+19.8%-37.5%+66.5%-116.8%+1.5%
All-TimeAll-Time-48.8%+19.8%-37.5%+66.5%-116.8%+1.5%

BBNX Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2025
-
-$8.73M(+35.8%)
-$56.58M(+1.5%)
Jun 2025
-
-$13.59M(+31.9%)
-$57.46M(-2.4%)
Mar 2025
-
-$19.98M(-39.9%)
-$56.10M(-16.2%)
Dec 2024
-$48.27M
-$14.28M(-48.5%)
-$48.27M(-19.7%)
Sep 2024
-
-$9.61M(+21.4%)
-$40.34M(+29.0%)
DateAnnualQuarterlyTTM
Jun 2024
-
-$12.24M(-0.8%)
-$56.83M(-27.4%)
Mar 2024
-
-$12.14M(-91.3%)
-$44.59M(-37.4%)
Dec 2023
-$32.45M(+46.1%)
-$6.35M(+75.7%)
-$32.45M(-24.3%)
Sep 2023
-
-$26.10M
-$26.10M
Dec 2022
-$60.21M
-
-

FAQ

  • What is Beta Bionics, Inc. annual cash from operations?
  • What is the all-time high annual cash from operations for Beta Bionics, Inc.?
  • What is Beta Bionics, Inc. annual cash from operations year-on-year change?
  • What is Beta Bionics, Inc. quarterly cash from operations?
  • What is the all-time high quarterly cash from operations for Beta Bionics, Inc.?
  • What is Beta Bionics, Inc. quarterly cash from operations year-on-year change?
  • What is Beta Bionics, Inc. TTM cash from operations?
  • What is the all-time high TTM cash from operations for Beta Bionics, Inc.?
  • What is Beta Bionics, Inc. TTM cash from operations year-on-year change?

What is Beta Bionics, Inc. annual cash from operations?

The current annual cash from operations of BBNX is -$48.27M

What is the all-time high annual cash from operations for Beta Bionics, Inc.?

Beta Bionics, Inc. all-time high annual cash from operations is -$32.45M

What is Beta Bionics, Inc. annual cash from operations year-on-year change?

Over the past year, BBNX annual cash from operations has changed by -$15.83M (-48.78%)

What is Beta Bionics, Inc. quarterly cash from operations?

The current quarterly cash from operations of BBNX is -$8.73M

What is the all-time high quarterly cash from operations for Beta Bionics, Inc.?

Beta Bionics, Inc. all-time high quarterly cash from operations is -$6.35M

What is Beta Bionics, Inc. quarterly cash from operations year-on-year change?

Over the past year, BBNX quarterly cash from operations has changed by +$884.00K (+9.20%)

What is Beta Bionics, Inc. TTM cash from operations?

The current TTM cash from operations of BBNX is -$56.58M

What is the all-time high TTM cash from operations for Beta Bionics, Inc.?

Beta Bionics, Inc. all-time high TTM cash from operations is -$26.10M

What is Beta Bionics, Inc. TTM cash from operations year-on-year change?

Over the past year, BBNX TTM cash from operations has changed by -$16.24M (-40.25%)
On this page